(PharmaNewsWire.Com, August 09, 2017 ) Multiple Myeloma is a rare form of cancer caused due to malignant plasma cells. When plasma cells become cancerous, they produce a tumour called plasmacytoma. If someone has more than one plasmacytoma, they have multiple myeloma. This is essentially a treatable cancer. DNA alterations, Stem cell transplants, Radiation therapy and surgeries are the available treatment options for multiple myeloma. The other factors which can have a significant impact on multiple myeloma treatment are age and general health, results of laboratory and cytogenetic (genomic) tests, symptoms and disease complications, prior myeloma treatment, patients lifestyle, goals, views on quality of life, and personal preferences.
The factors influencing the Global Market for Multiple Myeloma Therapeutics Market, either positively or negatively are presented in the DROC analysis. The market for multiple myeloma therapeutics is anticipated to grow with increasing incidences of the disease among population. Growing geriatric population across the globe is absolutely augmenting the growth of multiple myeloma therapeutics market during the forecast period. However, various patients suffer decline or ripen treatment resistance which is acting as a restrain for the market and it becomes necessary to develop harmless and effective treatments that extend the duration of retardation and increase survival.
For granular level understanding, the Multiple Myeloma Market is segmented based on the following categories with Market Size Estimations and Y-o-Y Forecasts presented for each sub-segments.
1) By Treatment Type Chemotherapy Anthracycline antibiotic Alkylating agent Targeted Therapy Proteasome inhibitor
2) By Drug Type Corticosteroids Dexamethasone (Decadron) Prednisone (Deltasone/Orasone) Immunomodulatory agents Thalidomide (Thalomid) Lenalidomide (Revlimid) Arsenic trioxide (Trisenox) Plerixafor (Mozobil)
Based on geography the market is analysed under various regions namely, North America, Latin America, Europe, Asia-Pacific and Middle-East & Africa. North America dominated the market with highest revenue because of stability of key manufacturers in the region. Due to increase in geriatric population in the countries like China and India, Asia-Pacific is expected to witness highest growth rate in the forecast period.
North America Multiple Myeloma Market Europe Multiple Myeloma Market Asia-Pacific Multiple Myeloma Market Latin America Multiple Myeloma Market Middle East and Africa Multiple Myeloma Market
Some of the key contributors in the industry include AB Science SA, AbbVie Inc., Ablynx NV, Acceleron Pharma Inc., IGF Oncology LLC. , ImmunGene Inc., Millennium Pharmaceuticals Inc., MimiVax LLC, Mirna Therapeutics, RedHill Biopharma Ltd., Rhizen Pharmaceuticals S.A., Terpenoid Therapeutics Inc. ,Teva Pharmaceutical Industries Ltd. ,TG Therapeutics Inc. and Johnson and Johnson.
The Multiple Myeloma Market study offers the following deliverables: Global, regional and country-level analysis and forecasts of the study market; providing Insights on the geographical areas in which this industry is blooming Segment-level analysis on basis of producttype, application, colour along with market size forecasts and y-o-y estimations to detect key areas of industry growth in detail Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics Study of macro and micro environmental factors that effect the global market presented in an extensive strategic analyses section containing PESTLE and Porters Five Forces Analyses A comprehensive listing of key market players along with company overview, product portfolios, key financial information (subjected to availability), SWOT analysis and analyst overview to study and sustain the market environment Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies Expertly devised Market Outlook along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
About Market Data Forecast: Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. From all-encompassing umbrella markets to extremely specific niche markets covering all the major regions across the globe as part of the research scope, their research services offer one of a kind specialities with competitive pricing options. For more info kindly visit, www.marketdataforecast.com
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
